[Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
D000368:Aged; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D001776:Blood Circulation Time; D001783:Blood Flow Velocity; D001795:Blood Pressure Determination; D002247:Carbon Isotopes / Q000378:metabolism; D004285:Dogs; D005260:Female; D005650:Fumarates / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007383:Intermittent Claudication / Q000188:drug therapy*; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011817:Rabbits; D012212:Rheology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002247:Carbon Isotopes; D005650:Fumarates; D014665:Vasodilator Agents
Behandlung peripherer und zerebraler Durchblutungsstörungen. Erfahrungen mit Bencyclan-hydrogenfumarat (Fludilat.